Chemokines and common variable immunodeficiency; Possible contribution of CCL19, CCL21 and CCR7 to immune dysregulation

Clinical and Experimental Immunology

Volumn 158, Issue 2, 2009, Pages 237-245

  Fevang, B ^a   Yndestad, A ^a   Damas J K ^b   Halvorsen, B ^a   Holm, A M ^c   Beiske, K ^c   Aukrust, P ^a,c   Froland S S ^a,c  

^a UNIVERSITY OF OSLO   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

CCL19; CCL21; CCR7; Chemokines; Common variable immunodeficiency

Indexed keywords

CHEMOKINE RECEPTOR CCR7; GAMMA INTERFERON; IMMUNOGLOBULIN; INTERLEUKIN 10; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; SECONDARY LYMPHOID TISSUE CHEMOKINE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD; CELL STIMULATION; CHRONIC INFLAMMATION; CLINICAL FEATURE; COMMON VARIABLE IMMUNODEFICIENCY; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; ENZYME IMMUNOASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNE DYSREGULATION; IMMUNITY; IMMUNOLOGICAL TOLERANCE; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN; T LYMPHOCYTE;

ADULT; CELLS, CULTURED; CHEMOKINE CCL19; CHEMOKINE CCL21; CHEMOKINES; COMMON VARIABLE IMMUNODEFICIENCY; CYTOKINES; FEMALE; GENE EXPRESSION; HUMANS; MALE; MIDDLE AGED; MONOCYTES; RECEPTORS, CCR7; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPLEEN; T-LYMPHOCYTE SUBSETS;

EID: 70349673292     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2009.04013.x     Document Type: Article

References (23)

1. Rosen FS, Eibl MM, Roifman CM et al. Primary immunodeficiency diseases. Report of an IUIS Scientific Committee. International Union of Immunological societies. Clin Exp Immunol 1999 118 (Suppl. 1 1 28.
2. Charo IF, Ransohoff RM. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 2006 354 : 610 621.
3. Forster R, valos-Misslitz Rot AC, Rot A. CCR7 and its ligands: balancing immunity and tolerance. Nat Rev Immunol 2008 8 : 362 371.
4. Muller G, Hopken UE, Lipp M. The impact of CCR7 and CXCR5 on lymphoid organ development and systemic immunity. Immunol Rev 2003 195 : 117 135. (Pubitemid 37153458)
5. Christopherson KW, Hood AF, Travers JB, Ramsey H, Hromas RA. Endothelial induction of the T-cell chemokine CCL21 in T-cell autoimmune diseases. Blood 2003 101 : 801 806.
6. Weninger W, Carlsen HS, Goodarzi M et al. Naive T cell recruitment to nonlymphoid tissues: a role for endothelium-expressed CC chemokine ligand 21 in autoimmune disease and lymphoid neogenesis. J Immunol 2003 170 : 4638 4648.
7. Burman A, Haworth O, Hardie DL et al. A chemokine-dependent stromal induction mechanism for aberrant lymphocyte accumulation and compromised lymphatic return in rheumatoid arthritis. J Immunol 2005 174 : 1693 1700.
8. Middel P, Raddatz D, Gunawan B, Haller F, Radzun HJ. Increased number of mature dendritic cells in Crohn's disease: evidence for a chemokine mediated retention mechanism. Gut 2006 55 : 220 227.
9. Damas JK, Smith C, Oie E et al. Enhanced expression of the homeostatic chemokines CCL19 and CCL21 in clinical and experimental atherosclerosis: possible pathogenic role in plaque destabilization. Arterioscler Thromb Vasc Biol 2007 27 : 614 620.
10. Holm AM, Sivertsen EA, Tunheim SH et al. Gene expression analysis of peripheral T cells in a subgroup of common variable immunodeficiency shows predominance of CCR7(-) effector-memory T cells. Clin Exp Immunol 2004 138 : 278 289.
11. Viallard JF, Blanco P, Andre M et al. CD8+HLA-DR+ T lymphocytes are increased in common variable immunodeficiency patients with impaired memory B-cell differentiation. Clin Immunol 2006 119 : 51 8.
12. Moratto D, Gulino AV, Fontana S et al. Combined decrease of defined B and T cell subsets in a group of common variable immunodeficiency patients. Clin Immunol 2006 121 : 203 214.
13. Aukrust P, Froland SS, Muller F. Raised serum neopterin levels in patients with primary hypogammaglobulinaemia; correlation to other immunological parameters and to clinical and histological features. Clin Exp Immunol 1992 89 : 211 216.
14. Aukrust P, Muller F, Froland SS. Elevated serum levels of interleukin-4 and interleukin-6 in patients with common variable immunodeficiency (CVI) are associated with chronic immune activation and low numbers of CD4+ lymphocytes. Clin Immunol Immunopathol 1994 70 : 217 224.
15. Aukrust P, Muller F, Froland SS. Enhanced generation of reactive oxygen species in monocytes from patients with common variable immunodeficiency. Clin Exp Immunol 1994 97 : 232 238.
16. Tsang KW, Tipoe GL. Bronchiectasis: not an orphan disease in the East. Int J Tuberc Lung Dis 2004 8 : 691 702.
17. Fevang B, Yndestad A, Damas JK et al. Chemokines and common variable immunodeficiency; possible contribution of the fractalkine system (CX3CL1/CX3CR1) to chronic inflammation. Clin Immunol 2009 130 : 151 161.
18. Hansen JB, Halvorsen DS, Haldorsen BC, Olsen R, Sjursen H, Kierulf P. Retention of phagocytic functions in cryopreserved human monocytes. J Leukoc Biol 1995 57 : 235 241.
19. Mori S, Nakano H, Aritomi K, Wang CR, Gunn MD, Kakiuchi T. Mice lacking expression of the chemokines CCL21-ser and CCL19 (plt mice) demonstrate delayed but enhanced T cell immune responses. J Exp Med 2001 193 : 207 218.
20. Schneider MA, Meingassner JG, Lipp M, Moore HD, Rot A. CCR7 is required for the in vivo function of CD4+ CD25+ regulatory T cells. J Exp Med 2007 204 : 735 745.
21. Kohout TA, Nicholas SL, Perry SJ, Reinhart G, Junger S, Struthers RS. Differential desensitization, receptor phosphorylation, beta-arrestin recruitment, and ERK1/2 activation by the two endogenous ligands for the CC chemokine receptor 7. J Biol Chem 2004 279 : 23214 23222.
22. Flanagan K, Moroziewicz D, Kwak H, Horig H, Kaufman HL. The lymphoid chemokine CCL21 costimulates naive T cell expansion and Th1 polarization of non-regulatory CD4+ T cells. Cell Immunol 2004 231 : 75 84.
23. Marsland BJ, Battig P, Bauer M et al. CCL19 and CCL21 induce a potent proinflammatory differentiation program in licensed dendritic cells. Immunity 2005 22 : 493 505.